A double‐blind, placebo‐controlled study of anti‐CD5 immunoconjugate in patients with rheumatoid arthritis

Objective. To evaluate the efficacy of an anti‐CD5 ricin‐linked immunoconjugate (CD5‐IC) in patients with rheumatoid arthritis (RA). Methods. A total of 104 evaluable patients were enrolled in a multicenter, double‐blind, multiple‐dose, placebo‐controlled study of CD5‐IC. Results. Treatment with CD5...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis and rheumatism 1996-07, Vol.39 (7), p.1102-1108
Hauptverfasser: Olsen, Nancy J., Brooks, Raye H., Cush, John J., Lipsky, Peter E., St. Clair, E. William, Matteson, Eric L., Gold, Kenneth N., Cannon, Grant W., Jackson, Christopher G., McCune, W. Joseph, Nelson, Betty, Lorenz, Todd, Strand, Vibeke
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!